[LRMR] YoY Quarter Result on 30-Sep-2019 [#Q3]

Stock
[LRMR] Larimar Therapeutics, Inc.
Announcement Date
06-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- -132.94%
YoY- 42.74%
Quarter Report
LRMR's Result
LRMR's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -8,320 -16,805 -10,274 -8,628 -15,067 -12,585 -14,675 -9.02%
Tax -193 0 -50 -4,286 0 0 0 -
NP -8,127 -16,805 -10,274 -8,628 -15,067 -12,585 -14,675 -9.37%
Tax Rate - - - - - - - -
Total Cost 8,127 16,805 10,274 8,628 15,067 12,585 14,675 -9.37%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
EPS -0.37 -0.92 -0.64 -0.94 -4.11 -4.58 -5.37 -35.95%
EPS Diluted -0.37 -0.92 -0.64 -0.94 -4.11 -4.58 -5.37 -35.95%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.